Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Loading SAGE News...
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||-0.14%||10.71||9.9%||$277.20m|
|PRGO||Perrigo Co. Plc||0.46%||68.45||4.8%||$176.72m|
|SHPG||Shire PLC Sponsored ADR||0.58%||174.15||0.3%||$168.21m|
|ENDP||Endo International Plc||-2.85%||9.87||8.9%||$124.21m|
|UTHR||United Therapeutics Corporation||0.79%||139.37||11.5%||$96.01m|
|JAZZ||Jazz Pharmaceuticals Plc||-0.43%||142.34||1.9%||$85.38m|
|PRXL||PAREXEL International Corporation||1.22%||62.00||6.7%||$68.50m|
|PCRX||Pacira Pharmaceuticals, Inc.||3.00%||48.15||16.9%||$64.12m|
|ICPT||Intercept Pharmaceuticals, Inc.||0.21%||116.25||22.8%||$54.02m|
|PTLA||Portola Pharmaceuticals, Inc.||1.40%||38.51||10.3%||$49.77m|
|HZNP||Horizon Pharma plc||0.21%||14.52||9.7%||$45.62m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||0.37%||119.50||9.9%||$40.74m|
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company engages in the development and commercialization of novel medicines to treat central nervous system disorders. Its product candidate includes SAGE-547, which is in clinical development for super-refractory status epileptics; SAGE-217; and SAGE-689, which are in IND-enabling toxicology and safety pharmacology testing. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.